
Gland Pharma Shares Soar After Successful USFDA Inspection
Gland Pharma Shares Soar After Successful USFDA Inspection
Gland Pharma experienced a significant boost in its share price, witnessing a 6.4% surge following the announcement of a successful inspection by the United States Food and Drug Administration (USFDA) at its Pashamylaram facility in Hyderabad.
USFDA Inspection and EIR Acquisition
The USFDA conducted a pre-market inspection of the Pashamylaram facility, focusing on its adherence to Quality System/Current Good Manufacturing Practice regulations for medical devices. Following the inspection, Gland Pharma received the Establishment Inspection Report (EIR), marking the successful conclusion of the inspection process.
Robust Performance in the Stock Market
Post the announcement, Gland Pharma’s shares peaked at ₹1,817.15 on the BSE, a 6.37% increase. This surge was accompanied by a more than fourfold increase in trading volume on the exchange, reflecting the market’s positive response to the company’s regulatory success.
Global Presence and Product Portfolio
Gland Pharma, a major player in the injectables market, has a global presence in over 60 countries, including the US, Europe, and Canada. The company operates primarily on a business-to-business model, offering a diverse range of injectable products such as vials, ampoules, and pre-filled syringes.
Financial Performance and Recent Approvals
Despite a 19.56% year-on-year decline in its consolidated net profit for Q2 of FY 2023-24, Gland Pharma’s revenue showed a significant increase, reflecting a 31.52% growth from the previous year. The company also secured provisional approval from the USFDA for an injection intended for treating low blood pressure in adults. Shares of Gland Pharma closed 2.88% higher at ₹1,757 per share
Latest Posts
- Ministry of Home Affairs Declares 23 Individuals as Terrorists Under UAPA, Targets LeT and JeM Operatives
July 4, 2026 | Breaking News - Doctors/Staff Wear Black Badges at Kishtwar Hospital Amid Row With MLA Shagun Parihar; MS Says, “Ready for En Masse Transfers”
July 4, 2026 | Breaking News, Jammu Kashmir, Kishtwar - Six Months After 15-Day Graft Probe Order, Jammu Kashmir Govt Yet to Make Inquiry Report Public
July 4, 2026 | Breaking News, Jammu Kashmir - Iran Holds Multi-Day State Funeral for Ayatollah Ali Khamenei Under Heavy Guard
July 4, 2026 | Breaking News, Politics, World - Maharashtra Bans Sale Of Energy Drinks Within 500 Metres Of Schools
July 4, 2026 | Breaking News, India - United Nations Warns Strong El Nino Likely Between July and September, Raising Extreme Weather Risk
July 3, 2026 | Breaking News, Weather, World - Pakistan Bus Plunge Into Ravine Kills 40 People
July 3, 2026 | Breaking News, Pakistan News, World - Over 100 Prominent Indians, Pakistanis appeal to PMs to Resume Dialoguing
July 1, 2026 | Breaking News, India, World - Hindus for Human Rights Welcomes United States Supreme Court Decision Upholding Birthright Citizenship
July 1, 2026 | Press Release - DeerRun Introduces New Connected Fitness Ecosystem Led by Apex Titan 1
July 1, 2026 | Press Release